Navigation Links
Heavy multivitamin use may be linked to advanced prostate cancer

While regular multivitamin use is not linked with early or localized prostate cancer, taking too many multivitamins may be associated with an increased risk for advanced or fatal prostate cancers, according to a study in the May 16 issue of the Journal of the National Cancer Institute.

Millions of Americans take multivitamins because of a belief in their potential health benefits, even though there is limited scientific evidence that they prevent chronic disease. Researchers have wondered what impact multivitamin use might have on cancer risk.

Karla Lawson, Ph.D., of the National Cancer Institute in Bethesda, Md., and colleagues followed 295,344 men enrolled in the National Institutes of Health-AARP Diet and Health Study to determine the association between multivitamin use and prostate cancer risk. After five years of follow-up, 10,241 men were diagnosed with prostate cancer, including 8,765 with localized cancers and 1,476 with advanced cancers.

The researchers found no association between multivitamin use and the risk of localized prostate cancer. But they did find an increased risk of advanced and fatal prostate cancer among men who used multivitamins more than seven times a week, compared with men who did not use multivitamins. The association was strongest in men with a family history of prostate cancer and men who also took selenium, beta-carotene, or zinc supplements.

“Because multivitamin supplements consist of a combination of several vitamins and men using high levels of multivitamins were also more likely to take a variety of individual supplements, we were unable to identify or quantify individual components responsible for the associations that we observed,?the authors write.

In an accompanying editorial, Goran Bjelakovic, M.D., of the University of Nis in Serbia, and Christian Gluud, M.D., of Copenhagen University Hospital in Denmark, discuss the positive and negative health effects of antioxida
'"/>

Source:Journal of the National Cancer Institute


Page: 1 2

Related biology news :

1. Heavy smoking cuts womens chance of pregnancy -- even with donated oocytes
2. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
3. Low level of extinction during ice age linked to adaptability
4. Improved statistical tools reveal many linked loci
5. Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels
6. Attacks of King George IIIs madness linked to key metabolism molecule
7. Gene controlling circadian rhythms linked to drug addiction
8. Physical and functional interaction of key cell growth molecules linked to cancer
9. VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells
10. Naturally occurring asbestos linked to lung cancer
11. Disappearing arctic lakes linked to climate change
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Heavy multivitamin use may linked advanced prostate cancer

(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced ... control Phase 3 study of Zerenex (ferric citrate), the ... treatment of hyperphosphatemia in patients with end-stage renal disease ... iRon delivery with FErric CiTrate in EsrD) was published ... Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... directed by Scripps Research Professor Benjamin Cravatt, Ph.D., ... of The Journal of Biological Chemistry. , The ... previously suggested-for the biosynthesis of neurotransmitter lipids, N-acyl ... anandamide. The high activity of the enzyme a/b ...
... within the cell nucleus and performs one of the ... machines that convert the genetic information carried by messenger ... , Gary Karpen and Jamy Peng, researchers in ... Lawrence Berkeley National Laboratory, have now discovered two pathways ...
... Scripps Research Professor Benjamin Cravatt, Ph.D., is being ... Journal of Biological Chemistry. , The new study ... the biosynthesis of neurotransmitter lipids, N-acyl ethanolamines (NAEs), ... high activity of the enzyme a/b hydrolase4 (Abh4) ...
Cached Biology News:Nanotechnology propels advances in regenerative medicine research 2Regulating the nuclear architecture of the cell 2Regulating the nuclear architecture of the cell 3Regulating the nuclear architecture of the cell 4Regulating the nuclear architecture of the cell 5Brown seaweed contains promising fat fighter, weight reducer 2
(Date:7/24/2014)... Draper University, a top program ... announce that for 6 weeks this summer, 39 ... on the Draper University campus in the heart ... focused on entrepreneurship, building real-world skills, and “learning ... its sixth cohort, continues to refresh its curriculum ...
(Date:7/24/2014)... 24, 2014   Cypher Genomics, Inc., ... of Adam Simpson as president and ... and comprehensive annotation and interpretation of individual human ... "Cypher,s technology has the potential to play ... diagnostic accuracy, optimizing therapeutic approaches and reducing adverse ...
(Date:7/24/2014)... San Diego, CA (PRWEB) July 24, 2014 ... in the reporting of molecular diagnostic test results. ... tracking capabilities necessary for the validation and reporting ... in oncology. Molecular diagnostics is a rapidly growing ... for infectious disease, genetic predisposition, cancer, and companion ...
(Date:7/23/2014)... United Arab Emirates (UAE) (PRWEB) July 23, 2014 ... Grace Century recently announced that its biobanking project, ... Vaught , Ph.D. to its growing Advisory Board. ... are very pleased to have Dr. Vaught onboard with ... scientific depth and expertise that Provia’s management team brings ...
Breaking Biology Technology:Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4
... (TCI), a Los,Angeles-based DNA and genomics research and ... office in the heart of Boston,s legal and,financial ... of,chemical and toxic exposures on human health and ... Consulting, TCI now offers a,range of business, financial, ...
... Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... will provide an,overview of the Company,s business at ... September 10, 2007 at 3:30 p.m. Eastern,Daylight Time. ... can be accessed on Watson,Pharmaceuticals, Investor Relations Web ...
... INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., Sept. 4, ... Dow Chemical Company (NYSE: DOW ), and ... Inc. (Nasdaq: EXEL ), announced today,that the ... includes the purchase of selected assets by Dow ...
Cached Biology Technology:Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases 2Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 2Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation 3
... ZMD.473. Immunogen: Synthetic peptide derived ... mouse junctophilin-2. Specificity: Specific for ... (positive controls: mouse skeletal muscle homogenates ... Applications: Western blotting Immunohistochemistry(froz) ImmunofluorescenceStorage: Store ...
Laminin gamma-2 (G-16)...
ABIN-2 Polyclonal Ab 100 ug rabbit polyclonal antibody. Detects ABIN-2 in human/mouse. Tested in WB....
Syd-2 (cL-19)...
Biology Products: